TRIADX Trademark

Trademark Overview

On Monday, July 21, 2025, a trademark application was filed for TRIADX with the United States Patent and Trademark Office. The USPTO has given the TRIADX trademark a serial number of 99294671. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, July 21, 2025. This trademark is owned by NextPhaseDx, LLC. The TRIADX trademark is filed in the Medical Instrument Products category with the following description:

Medical diagnostic apparatus for detecting biomarkers of ionizing radation exposure in human biological samples.
triadx

General Information

Serial Number99294671
Word MarkTRIADX
Filing DateMonday, July 21, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, July 21, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical diagnostic apparatus for detecting biomarkers of ionizing radation exposure in human biological samples.

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, July 22, 2025
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNextPhaseDx, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLocust Grove, VA 22508

Trademark Events

Event DateEvent Description
Monday, July 21, 2025NEW APPLICATION ENTERED
Monday, July 21, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, July 22, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

triadx exposure human biological samples radation ionizing diagnostic apparatus detecting biomarkers